LIMES Schlosskliniken AG (ETR:LIK)
570.00
0.00 (0.00%)
Aug 5, 2026, 9:02 AM CET
LIMES Schlosskliniken AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 170 | 105 | 97 | 83 | 94 | 60 | |
Market Cap Growth | 42.96% | 8.36% | 16.90% | -11.25% | 55.34% | 101.96% |
Enterprise Value | 171.76 | 107.41 | 98.45 | 86.35 | 92.03 | 62.34 |
Last Close Price | 570.00 | 354.00 | 332.00 | 284.00 | 320.00 | 206.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.82 | 18.52 | 31.29 | 24.53 | 22.32 | 15.32 |
Forward PE | 16.01 | 14.04 | 18.51 | - | - | - |
PS Ratio | 3.40 | 1.96 | 2.55 | 2.19 | 3.12 | 2.39 |
PB Ratio | 6.33 | 4.17 | 5.31 | 5.50 | 8.45 | 9.72 |
P/TBV Ratio | 9.39 | 5.83 | 10.17 | 17.18 | 36.13 | - |
P/FCF Ratio | 149.24 | 92.69 | 39.02 | - | 14.00 | 13.81 |
P/OCF Ratio | 17.38 | 10.79 | 13.04 | 13.23 | 11.66 | 12.65 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.44 | 1.99 | 2.58 | 2.28 | 3.06 | 2.47 |
EV/EBITDA Ratio | 13.43 | 8.40 | 13.96 | 11.26 | 10.64 | 10.36 |
EV/EBIT Ratio | 18.45 | 11.54 | 22.95 | 17.18 | 15.34 | 13.76 |
EV/FCF Ratio | 150.94 | 94.39 | 39.46 | - | 13.74 | 14.25 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.40 | 0.40 | 0.53 | 0.61 | 0.81 | 0.69 |
Debt / EBITDA Ratio | 0.84 | 0.84 | 1.49 | 1.32 | 1.04 | 0.72 |
Debt / FCF Ratio | 9.43 | 9.43 | 4.20 | - | 1.35 | 0.99 |
Net Debt / Equity Ratio | 0.02 | 0.02 | -0.02 | 0.10 | -0.17 | 0.30 |
Net Debt / EBITDA Ratio | 0.03 | 0.03 | -0.06 | 0.21 | -0.22 | 0.31 |
Net Debt / FCF Ratio | 0.37 | 0.37 | -0.16 | -4.98 | -0.28 | 0.42 |
Asset Turnover | 1.29 | 1.29 | 1.06 | 1.27 | 1.33 | 1.67 |
Inventory Turnover | 48.84 | 48.84 | 35.52 | 41.83 | 58.87 | 385.19 |
Quick Ratio | 4.06 | 4.06 | 3.22 | 3.83 | 5.62 | 3.43 |
Current Ratio | 4.13 | 4.13 | 3.33 | 3.94 | 4.11 | 1.68 |
Return on Equity (ROE) | 30.17% | 30.17% | 17.70% | 28.08% | 55.57% | 91.41% |
Return on Assets (ROA) | 17.24% | 17.24% | 9.32% | 14.31% | 23.08% | 28.60% |
Return on Invested Capital (ROIC) | 26.50% | 30.93% | 17.78% | 31.14% | 59.58% | 72.01% |
Return on Capital Employed (ROCE) | 25.33% | 25.33% | 13.72% | 18.84% | 29.47% | 32.78% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.35% | 5.40% | 3.20% | 4.08% | 4.48% | 6.53% |
FCF Yield | 0.67% | 1.08% | 2.56% | - | 7.14% | 7.24% |
Buyback Yield / Dilution | -1.62% | -1.62% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | -1.62% | -1.62% | 0.00% | 0.00% | 0.00% | 0.00% |